LAMOND STEPHEN J (See Remarks) purchased 39.3% of their position (5.60K shares) of PEAK BIO, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 2 purchases
Filed: 9/28/2023ACC: 0000950170-23-050436
DirectorOfficer· See Remarks
Since Nov 2022
+5.60K
Net shares
Net buyer
$0.00
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5.60K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
—
Trade value
—
% of position
21.1%
9/26/2023
14.25K→17.25K
Common Stock
Direct
Shares
+2.60K
Price / share
—
Trade value
—
% of position
15.1%
9/27/2023
17.25K→19.85K
Total
Net shares
+5.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/26/2023 | P · Purchase | +3K | — | — | 21.1% | 14.25K | 17.25K |
| Common Stock Direct | 9/27/2023 | P · Purchase | +2.60K | — | — | 15.1% | 17.25K | 19.85K |
| Total | +5.60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported